Texas Children’s Cancer & Hematology Center Faculty Earn Approximately $2 Million in New Research Funding

Texas Children’s Cancer & Hematology Center is proud to recognize faculty members who have recently secured approximately $2 million in new research funding to advance care for children with cancer and serious blood disorders.

The newly funded projects support research across a broad spectrum of pediatric health. Areas of focus include cancer biology, genetic drivers of disease, lymphatic disorders, neurodevelopmental outcomes, pediatric brain tumors, and sickle cell disease. The awards will help investigators expand scientific knowledge while advancing discoveries that have the potential to improve care for children and adolescents.

The following principal investigators and projects recently received funding (pictured L–R, top to bottom):

Eveline Barbieri, MD, PhD

• A Novel GEMM to Elucidate the Role of CHAF1A in Neuroblastoma Development

• Funding Agency: National Institutes of Health (NIH)

Erin C. Peckham Gregory, PhD, MPH

• Characterization of Germline and Somatic Genetic Variants in Langerhans Cell Histiocytosis Pathogenesis

• Funding Agency: National Institutes of Health (NIH)

Ionela Iacobas, MD

• ELIXIR: Eliminating Lymphatic Irregularities by Cross-Disciplinary Intelligent Regulation

• Funding Agency: Advanced Research Projects Agency for Health (ARPA-H)

Venée N. Tubman, MD, MMS

• Mechanisms of Marginal Zone Depletion in Sickle Cell Spleen Tissue

• Funding Agency: National Institutes of Health (NIH)

Kimberly P. Raghubar, PhD (Psychology Division)

• REST: REsolving Sleep Troubles in Childhood Leukemia

• Funding Agency: National Cancer Institute

Michael Taylor, MD, PhD, FRCS(C)

• 1q Gain and the Stem-Like State in PFA Ependymomas

• Funding Agency: The Brain Tumour Charity

Congratulations to these investigators and their teams, and thank you to our funding partners for their continued support. By enabling this research, they are helping accelerate discoveries that improve our understanding of disease and drive future advances in pediatric medicine.

Learn more about previous research grants here.